OM DENNE PODKAST 🔗

Opdateringsfrekvens:
daily
Gjennomsnittlig lydlængde:
29 minutes
Gæsteinterviews
Engelsk
USA
269 episoder
siden 1. januar 1970
episodic

NYESTE EPISODE 🔗

We were delighted to be joined by Dr. Sam Blackman, a physician-scientist, biotech entrepreneur and investor who has built a fascinating career across medicine, drug development and biotechnology. Sam trained as a physician and spent much of his early career focused on pediatric oncology before mov…

SØK BLANT TIDLIGERE EPISODER

Søk etter gamle episoder av The BioHub - by Avetix.

SISTE EPISODER

We were delighted to be joined by two highly experienced leaders in the biotechnology industry, Howard Berman, Ph.D., and Kia Motesharei, Ph.D. Both Howard and Kia have built impressive careers across biotechnology, capital markets, business development and strategic transactions, with a track reco…
In this episode of The BioHub Podcast, Ben sits down with Dr. Inder Kaul, Chief Medical Officer at Draig Therapeutics, to discuss the evolution of neuropsychiatric drug development and what it takes to translate novel neuroscience into meaningful medicines for patients. Inder brings decades of glob…
In this episode of The BioHub by Avetix, I’m joined by Eran Seger, CEO and Co-Founder of Protai. Eran shares his unique journey into biotech and the inspiration behind founding Protai, where the team is combining proteomics and AI to better understand disease biology and improve how new medicines …
We welcomed Mandana Honu onto the BioHub podcast
In this episode of The BioHub Podcast, Ben is joined by Dr. Marc Hedrick, President & CEO of Cerenome, and Russell Bradley, President & General Manager of CNSide Diagnostics. We explore why CNS cancers remain so difficult to diagnose and treat, and how Cerenome is attempting to address both…
In this episode of The BioHub by Avetix, I’m joined by Dan O’Connell, President and CEO of Acumen Pharmaceuticals. Dan shares his journey from neuroscience investing and company creation into the CEO role, and how he has helped take Acumen from a private, preclinical biotech into a publicly traded…
In this episode of The BioHub by Avetix, I’m joined by Paul Hastings, CEO of Nkarta. Paul has spent more than three decades in biotech, leading companies across oncology, rare disease and cell therapy, while also becoming one of the industry’s most prominent patient advocates. At Nkarta, he’s now …
We welcomed Lei Fang the CEO of Excalipoint to the BioHub
Today we’re joined by Jay Fine, President of Research & Development at EvolveImmune Therapeutics. Jay has spent more than 30 years working across drug discovery and development, with a career spanning immunology, immuno-oncology, inflammatory diseases and respiratory disorders. Before joining E…
Ansvarsfraskrivelse: Podkasten og kunstværket, det finnes indlejret på denne siden, er fra Max Brennan - Biotech HeadHunter, som tilhører dens eier og ikke er tilknyttet eller godkjent av Listen Notes, Inc.